116 related articles for article (PubMed ID: 8287551)
1. Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure.
Jakob G; Mair J; Vorderwinkler KP; Judmaier G; König P; Zwierzina H; Pichler M; Puschendorf B
Clin Chem; 1994 Jan; 40(1):96-100. PubMed ID: 8287551
[TBL] [Abstract][Full Text] [Related]
2. Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.
Jakob G; Mair J; Pichler M; Puschendorf B
Br Heart J; 1995 Feb; 73(2):145-50. PubMed ID: 7696024
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
Tsutamoto T; Kanamori T; Wada A; Kinoshita M
J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
[TBL] [Abstract][Full Text] [Related]
5. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases.
Vorderwinkler KP; Artner-Dworzak E; Jakob G; Mair J; Diensti F; Pichler M; Puschendorf B
Clin Chem; 1991 Feb; 37(2):186-90. PubMed ID: 1847093
[TBL] [Abstract][Full Text] [Related]
6. Levels of atrial natriuretic factor in the plasma and urine of patients with and without heart failure.
Agnoletti G; Panzali AF; Ferrari R
Int J Cardiol; 1993 Jul; 40(2):179-82. PubMed ID: 8394286
[TBL] [Abstract][Full Text] [Related]
7. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
[TBL] [Abstract][Full Text] [Related]
8. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Matsuo H
J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
[TBL] [Abstract][Full Text] [Related]
9. Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.
Chaykovska L; Heunisch F; von Einem G; Hocher CF; Tsuprykov O; Pavkovic M; Sandner P; Kretschmer A; Chu C; Elitok S; Stasch JP; Hocher B
PLoS One; 2018; 13(4):e0195828. PubMed ID: 29649334
[TBL] [Abstract][Full Text] [Related]
10. Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.
Wood PJ; Ross G; Smith CL
J Clin Pathol; 1979 Oct; 32(10):998-1002. PubMed ID: 230205
[TBL] [Abstract][Full Text] [Related]
11. Plasma cyclic guanosine monophosphate in chronic heart failure: hemodynamic and neurohormonal correlations and response to nitrate therapy.
Shotan A; Mehra A; Ostrzega E; Hsueh W; Do YS; Fisher DA; Hurst A; Johnson JV; Elkayam U
Clin Pharmacol Ther; 1993 Dec; 54(6):638-44. PubMed ID: 7903916
[TBL] [Abstract][Full Text] [Related]
12. Discrepancy between plasma and aortic wall cyclic guanosine monophosphate in an experimental model of congestive heart failure.
Arnal JF; Hofmann F; Michel JB
Cardiovasc Res; 1993 Jun; 27(6):1094-100. PubMed ID: 8221770
[TBL] [Abstract][Full Text] [Related]
13. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats.
Michel JB; Mercadier JJ; Galen FX; Urbain R; Dussaule JC; Philippe M; Corvol P
Cardiovasc Res; 1990 Nov; 24(11):946-52. PubMed ID: 2176935
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma cyclic nucleotide concentrations in congestive heart failure.
Ogawa K; Shiozu H; Mizuno K; Ban M; Ito T; Satake T
Br Heart J; 1984 Nov; 52(5):524-9. PubMed ID: 6093837
[TBL] [Abstract][Full Text] [Related]
15. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
16. ANF-mediated renal cGMP generation in congestive heart failure.
Margulies KB; Heublein DM; Perrella MA; Burnett JC
Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
[TBL] [Abstract][Full Text] [Related]
17. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
Blonde L; Wehmann RE; Steiner AL
J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
[TBL] [Abstract][Full Text] [Related]
19. [Cyclic GMP as a biomarker for cardiovascular disease and cancer].
Ulvestad L; Sager G
Tidsskr Nor Laegeforen; 2005 Jan; 125(1):27-8. PubMed ID: 15643459
[TBL] [Abstract][Full Text] [Related]
20. Guanosine 3', 5'-cyclic monophosphate level in plasma of patients with cancer and various diseases.
Miyagi Y
Bull Tokyo Med Dent Univ; 1979 Jun; 26(2):81-4. PubMed ID: 221127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
